Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
- 1 November 2005
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 108 (1) , 84-96
- https://doi.org/10.1016/j.jconrel.2005.07.013
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and PermeabilityJournal of Drug Targeting, 2004
- Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticlesBiomaterials, 2004
- Antinociceptive Structure-Activity Studies with Enkephalin-Based Opioid GlycopeptidesThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Novel delivery systems fro drug targeting to the brainDrugs of the Future, 2004
- Glycopeptide-Membrane Interactions: Glycosyl Enkephalin Analogues Adopt Turn Conformations by NMR and CD in Amphipathic MediaJournal of the American Chemical Society, 2003
- Nanoparticle Technology for Drug Delivery Across the Blood-Brain BarrierDrug Development and Industrial Pharmacy, 2002
- Cell-penetrating peptidesPublished by Elsevier ,2000
- Bioavailability and Transport of Peptides and Peptide Drugs into the BrainPeptides, 1997
- Glycosylated Peptide Hormones: Pharmacological Properties and Conformational Studies of Analogs of [1-Desamino,8-D-arginine]vasopressinJournal of Medicinal Chemistry, 1995
- Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma ProteinsJournal of Neurochemistry, 1990